Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope-Reference-Cited by-同舟云学术

Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope

Published:2017-01-24 Issue:2 Volume:56 Page:585-599
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Theunis Clara¹,Adolfsson Oskar²,Crespo-Biel Natalia¹,Piorkowska Kasia²,Pihlgren Maria²,Hickman David T.²,Gafner Valérie²,Borghgraef Peter¹,Devijver Herman¹,Pfeifer Andrea²,Van Leuven Fred¹,Muhs Andreas²

Affiliation:

1. Experimental Genetics Group - LEGTEGG, Department of Human Genetics, KULeuven, Leuven, Belgium

2. AC Immune SA, EPFL Innovation Park, Building B, Lausanne, Switzerland

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference45 articles.

1. Cognitive enhancers (Nootropics). Part 1: Drugs interacting with receptors. Update 2014;Froestl;J Alzheimers Dis,2014

2. Cognitive enhancers (nootropics). Part 2: Drugs interacting with enzymes. Update 2014;Froestl;J Alzheimers Dis,2014

3. Clinical trials and late-stage drug development for Alzheimer’s disease: An appraisal from 1984 to 2014;Schneider;J Intern Med,2014

4. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia;Spillantini;Proc Natl Acad Sci U S A,1998

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tau-Targeted Immunotherapy for Alzheimer's Disease: Insight into Clinical Trials;OBM Neurobiology;2024-08-07

2. Recent trends in treatment strategies for Alzheimer's disease and the challenges: A topical advancement;Ageing Research Reviews;2024-02

3. A critical appraisal of tau‐targeting therapies for primary and secondary tauopathies;Alzheimer's & Dementia;2021-09-17

4. Nanoconstructs as a versatile tool for detection and diagnosis of Alzheimer biomarkers;Nanotechnology;2021-01-13

5. Advances and considerations in AD tau-targeted immunotherapy;Neurobiology of Disease;2020-02